1. Cancer Biology
Download icon

Acid-base transporters and pH dynamics in human breast carcinomas predict proliferative activity, metastasis, and survival

  1. Nicolai J Toft
  2. Trine V Axelsen
  3. Helene L Pedersen
  4. Marco Mele
  5. Mark Burton
  6. Eva Balling
  7. Tonje Johansen
  8. Mads Thomassen
  9. Peer M Christiansen
  10. Ebbe Boedtkjer  Is a corresponding author
  1. Aarhus University, Denmark
  2. Regionshospitalet Randers, Denmark
  3. University of Southern Denmark, Denmark
Research Article
  • Cited 0
  • Views 546
  • Annotations
Cite this article as: eLife 2021;10:e68447 doi: 10.7554/eLife.68447

Abstract

Breast cancer heterogeneity in histology and molecular subtype influences metabolic and proliferative activity and hence the acid load on cancer cells. We hypothesized that acid-base transporters and intracellular pH (pHi) dynamics contribute inter-individual variability in breast cancer aggressiveness and prognosis. We show that Na+,HCO3--cotransport and Na+/H+-exchange dominate cellular net acid extrusion in human breast carcinomas. Na+/H+-exchange elevates pHi preferentially in estrogen receptor-negative breast carcinomas, whereas Na+,HCO3--cotransport raises pHi more in invasive lobular than ductal breast carcinomas and in higher malignancy grade breast cancer. HER2-positive breast carcinomas have elevated protein expression of Na+/H+-exchanger NHE1/SLC9A1 and Na+,HCO3--cotransporter NBCn1/SLC4A7. Increased dependency on Na+,HCO3--cotransport associates with severe breast cancer: enlarged CO2/HCO3--dependent rises in pHi predict accelerated cell proliferation; whereas enhanced CO2/HCO3--dependent net acid extrusion, elevated NBCn1 protein expression, and reduced NHE1 protein expression predict lymph node metastasis. Accordingly, we observe reduced survival for patients suffering from Luminal A or Basal-like/triple-negative breast cancer with high SLC4A7 and/or low SLC9A1 mRNA expression. We conclude that the molecular mechanisms of acid-base regulation depend on clinicopathological characteristics of breast cancer patients. NBCn1 expression and dependency on Na+,HCO3--cotransport for pHi regulation, measured in biopsies of human primary breast carcinomas, independently predict proliferative activity, lymph node metastasis, and patient survival.

Data availability

- In order to comply with the ethical approval, we share the human data presented in Figure 1-8 and corresponding Figure Supplements (data on acid-base transport activity, intracellular pH, and protein expression of transporters linked to clinicopathological information) in de-identified form. Following consultation with the legal team at the Regional Committee on Health Research Ethics, we have generated dataset files where restricted information is grouped in intervals each consisting of no less than five individuals. To provide the reader with the best possible data insight, we also show Figure Supplements with more detailed and advanced plots of the data and include the corresponding de-identified dataset.- The meta analyses presented in Figure 9, 10, and corresponding figure supplements (data on RNA expression linked to patient survival) are based on data that have previously been published by other investigators (references 28-34), as detailed in the manuscript and the dataset list.

The following previously published data sets were used

Article and author information

Author details

  1. Nicolai J Toft

    Department of Biomedicine, Aarhus University, Aarhus C, Denmark
    Competing interests
    No competing interests declared.

  2. Trine V Axelsen

    Department of Biomedicine, Aarhus University, Aarhus C, Denmark
    Competing interests
    No competing interests declared.

  3. Helene L Pedersen

    Department of Pathology, Regionshospitalet Randers, Randers, Denmark
    Competing interests
    No competing interests declared.

  4. Marco Mele

    Department of Surgery, Regionshospitalet Randers, Randers, Denmark
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8156-7804

  5. Mark Burton

    Department of Clinical Genetics, University of Southern Denmark, Odense, Denmark
    Competing interests
    No competing interests declared.

  6. Eva Balling

    Department of Surgery, Regionshospitalet Randers, Randers, Denmark
    Competing interests
    No competing interests declared.

  7. Tonje Johansen

    Department of Pathology, Regionshospitalet Randers, Randers, Denmark
    Competing interests
    No competing interests declared.

  8. Mads Thomassen

    Department of Clinical Genetics, University of Southern Denmark, Odense, Denmark
    Competing interests
    No competing interests declared.

  9. Peer M Christiansen

    Department of Surgery, Regionshospitalet Randers, Randers, Denmark
    Competing interests
    No competing interests declared.

  10. Ebbe Boedtkjer

    Department of Biomedicine, Aarhus University, Aarhus C, Denmark
    For correspondence
    eb@biomed.au.dk
    Competing interests
    Ebbe Boedtkjer, is an inventor on patents covering NBCn1 as target for cancer therapy (EP 3271402)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5078-9279

Funding

Sundhed og Sygdom, Det Frie Forskningsråd (7025-00050B)

  • Ebbe Boedtkjer

Novo Nordisk Fonden (NNF18OC0053037)

  • Ebbe Boedtkjer

Danish Cancer Society (R136-A8670)

  • Nicolai J Toft

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All participants gave written informed consent. The Mid-Jutland regional division of the Danish Committee on Health Research Ethics (M-20100288) and the Danish Data Protection Agency (1-16-02-191-16) approved the procedures for tissue sampling and data handling, respectively.

Reviewing Editor

  1. Caigang Liu, Shengjing Hospital of China Medical University, China

Publication history

  1. Received: March 16, 2021
  2. Accepted: July 2, 2021
  3. Accepted Manuscript published: July 5, 2021 (version 1)
  4. Version of Record published: July 15, 2021 (version 2)

Copyright

© 2021, Toft et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 546
    Page views
  • 71
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Categories and tags

Research organism

Further reading

    1. Cancer Biology
    2. Cell Biology

    Fine-tuned repression of Drp1 driven mitochondrial fission primes a 'stem/progenitor-like state' to support neoplastic transformation

    Brian Spurlock et al.
    Short Report

    Gene knockout of the master regulator of mitochondrial fission, Drp1, prevents neoplastic transformation. Also, mitochondrial fission and its opposing process of mitochondrial fusion are emerging as crucial regulators of stemness. Intriguingly, stem/progenitor cells maintaining repressed mitochondrial fission are primed for self-renewal and proliferation. Using our newly derived carcinogen transformed human cell model we demonstrate that fine-tuned Drp1 repression primes a slow cycling 'stem/progenitor-like state', which is characterized by small networks of fused mitochondria and a gene-expression profile with elevated functional stem/progenitor markers (Krt15, Sox2 etc) and their regulators (Cyclin E). Fine tuning Drp1 protein by reducing its activating phosphorylation sustains the neoplastic stem cell markers. Whereas, fine-tuned reduction of Drp1 protein maintains the characteristic mitochondrial shape and gene-expression of the primed 'stem/progenitor-like state' to accelerate neoplastic transformation, and more complete reduction of Drp1 protein prevents it. Therefore, our data highlights a 'goldilocks'; level of Drp1 repression supporting stem/progenitor state dependent neoplastic transformation.

    1. Cancer Biology
    2. Neuroscience

    Stimulation of hypothalamic oxytocin neurons suppresses colorectal cancer progression in mice

    Susu Pan et al.
    Research Article

    Emerging evidence suggests that the nervous system is involved in tumor development in the periphery, however, the role of central nervous system remains largely unknown. Here, by combining genetic, chemogenetic, pharmacological and electrophysiological approaches, we show that hypothalamic oxytocin (Oxt)-producing neurons modulate colitis-associated cancer (CAC) progression in mice. Depletion or activation of Oxt neurons could augment or suppress CAC progression. Importantly, brain treatment with celastrol, a pentacyclic triterpenoid, excites Oxt neurons and inhibits CAC progression, and this anti-tumor effect was significantly attenuated in Oxt neuron-lesioned mice. Furthermore, brain treatment with celastrol suppresses sympathetic neuronal activity in the celiac-superior mesenteric ganglion (CG-SMG), and activation of β2 adrenergic receptor abolishes the anti-tumor effect of Oxt neuron activation or centrally administered celastrol. Taken together, these findings demonstrate that hypothalamic Oxt neurons regulate CAC progression by modulating the neuronal activity in the CG-SMG. Stimulation of Oxt neurons using chemicals, eg. celastrol, might be a novel strategy for colorectal cancer treatment.

    1. Cancer Biology
    2. Cell Biology

    Identification of abscission checkpoint bodies as structures that regulate ESCRT factors to control abscission timing

    Lauren K Williams et al.
    Research Article Updated

    The abscission checkpoint regulates the ESCRT membrane fission machinery and thereby delays cytokinetic abscission to protect genomic integrity in response to residual mitotic errors. The checkpoint is maintained by Aurora B kinase, which phosphorylates multiple targets, including CHMP4C, a regulatory ESCRT-III subunit necessary for this checkpoint. We now report the discovery that cytoplasmic abscission checkpoint bodies (ACBs) containing phospho-Aurora B and tri-phospho-CHMP4C develop during an active checkpoint. ACBs are derived from mitotic interchromatin granules, transient mitotic structures whose components are housed in splicing-related nuclear speckles during interphase. ACB formation requires CHMP4C, and the ESCRT factor ALIX also contributes. ACB formation is conserved across cell types and under multiple circumstances that activate the checkpoint. Finally, ACBs retain a population of ALIX, and their presence correlates with delayed abscission and delayed recruitment of ALIX to the midbody where it would normally promote abscission. Thus, a cytoplasmic mechanism helps regulate midbody machinery to delay abscission.